Littlejohn & Co. LLC Sells 149,123 Shares of Aveanna Healthcare Holdings Inc. $AVAH

Key Points

• Littlejohn & Co. LLC reduced its stake in Aveanna Healthcare Holdings by 1.9%, selling 149,123 shares, and now holds 7,561,740 shares, which accounts for 21.3% of its portfolio.
• Insider sales included Robert M. Williams, Jr. selling 750,000 shares for approximately $3.9 million, reducing his ownership by 2.53%, while insiders collectively sold nearly 7 million shares valued at over $37 million in recent months.
• Aveanna's stock price opened at $7.15, with analysts giving it a consensus rating of "Hold" and a price target of $6.45, following mixed ratings from various brokerages.

Littlejohn & Co. LLC lowered its stake in Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH - Free Report) by 1.9% in the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 7,561,740 shares of the company's stock after selling 149,123 shares during the quarter. Aveanna Healthcare makes up approximately 21.3% of Littlejohn & Co. LLC's investment portfolio, making the stock its 2nd largest position. Littlejohn & Co. LLC owned 3.88% of Aveanna Healthcare worth $40,985,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also recently made changes to their positions in the stock. Price T Rowe Associates Inc. MD lifted its holdings in shares of Aveanna Healthcare by 5.2% in the fourth quarter. Price T Rowe Associates Inc. MD now owns 53,699 shares of the company's stock worth $246,000 after acquiring an additional 2,649 shares during the last quarter. Rhumbline Advisers lifted its holdings in shares of Aveanna Healthcare by 4.0% in the first quarter. Rhumbline Advisers now owns 75,581 shares of the company's stock worth $410,000 after acquiring an additional 2,918 shares during the last quarter. Bank of New York Mellon Corp raised its holdings in Aveanna Healthcare by 4.2% in the 1st quarter. Bank of New York Mellon Corp now owns 114,881 shares of the company's stock valued at $623,000 after buying an additional 4,655 shares during the last quarter. Tower Research Capital LLC TRC boosted its position in Aveanna Healthcare by 662.2% during the 4th quarter. Tower Research Capital LLC TRC now owns 7,889 shares of the company's stock worth $36,000 after buying an additional 6,854 shares during the period. Finally, BNP Paribas Financial Markets acquired a new stake in Aveanna Healthcare during the 4th quarter worth approximately $35,000. Institutional investors own 87.96% of the company's stock.

Aveanna Healthcare Stock Performance

Shares of NASDAQ AVAH traded down $0.04 during midday trading on Monday, reaching $7.04. The stock had a trading volume of 1,155,582 shares, compared to its average volume of 527,531. The firm has a market cap of $1.47 billion, a price-to-earnings ratio of 88.00 and a beta of 1.95. Aveanna Healthcare Holdings Inc. has a twelve month low of $3.67 and a twelve month high of $7.61. The company's 50 day moving average price is $4.77 and its 200 day moving average price is $4.87.

Insider Transactions at Aveanna Healthcare

In other news, insider Patrick A. Cunningham sold 18,500 shares of the business's stock in a transaction that occurred on Friday, June 13th. The shares were sold at an average price of $4.93, for a total value of $91,205.00. Following the transaction, the insider owned 327,869 shares in the company, valued at approximately $1,616,394.17. The trade was a 5.34% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, major shareholder Robert M. Williams, Jr. sold 750,000 shares of the business's stock in a transaction that occurred on Tuesday, June 10th. The stock was sold at an average price of $5.20, for a total transaction of $3,900,000.00. Following the completion of the transaction, the insider owned 28,890,756 shares in the company, valued at $150,231,931.20. This trade represents a 2.53% decrease in their position. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 2,295,145 shares of company stock worth $11,941,141. Company insiders own 7.00% of the company's stock.

Analyst Ratings Changes

Several equities research analysts recently commented on the stock. Truist Financial cut their target price on shares of Aveanna Healthcare from $6.00 to $5.00 and set a "hold" rating on the stock in a research report on Wednesday, July 16th. Barclays assumed coverage on shares of Aveanna Healthcare in a research report on Wednesday, July 2nd. They set an "equal weight" rating and a $5.50 target price on the stock. Raymond James Financial upgraded shares of Aveanna Healthcare from a "market perform" rating to an "outperform" rating and set a $9.00 target price on the stock in a research report on Monday, August 11th. Wall Street Zen upgraded shares of Aveanna Healthcare from a "buy" rating to a "strong-buy" rating in a research report on Saturday, August 9th. Finally, UBS Group lifted their target price on shares of Aveanna Healthcare from $5.00 to $6.75 and gave the stock a "sell" rating in a research report on Tuesday, August 12th. One investment analyst has rated the stock with a sell rating, two have issued a hold rating, two have given a buy rating and one has given a strong buy rating to the stock. Based on data from MarketBeat.com, the stock currently has an average rating of "Moderate Buy" and a consensus target price of $6.45.

About Aveanna Healthcare

Aveanna Healthcare Holdings Inc, a diversified home care platform company, provides pediatric and adult healthcare services in the United States. Its patient-centered care delivery platform allows patients to remain in their homes and minimizes the overutilization of high-cost care settings, such as hospitals or skilled nursing facilities.